MEINIAN ONEHEALTH HEALTHCARE HOLDINGS CO., LTD. Meinian Onehealth Healthcare Holdings Co., Ltd. Share Price
Equities
002044
CNE000001LV7
Healthcare Facilities & Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.81 CNY | +5.02% |
|
+5.25% | -19.97% |
| Sales 2024 * | 11.87B 1.64B 131B | Sales 2025 * | 13.38B 1.85B 148B | Capitalization | 18.71B 2.58B 207B |
|---|---|---|---|---|---|
| Net income 2024 * | 840M 116M 9.28B | Net income 2025 * | 1.12B 154M 12.37B | EV / Sales 2024 * | 1.58 x |
| Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 1.4 x |
| P/E ratio 2024 * |
22.6
x | P/E ratio 2025 * |
16.8
x | Employees | - |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 67.83% |
More Fundamentals
* Assessed data
More news
| 1 day | +5.02% | ||
| 1 week | +5.25% | ||
| Current month | -4.56% | ||
| 1 month | -3.41% | ||
| 3 months | -3.41% | ||
| 6 months | -22.54% | ||
| Current year | -19.97% |
1 week
4.43
4.83
1 month
4.435.13
Current year
4.436.02
1 year
4.437.42
3 years
3.9512.67
5 years
3.9520.15
10 years
3.9521.13
| Managers | Title | Age | Since |
|---|---|---|---|
Tao Xu
CEO | Chief Executive Officer | 51 | 24/06/21 |
Rong Yu
FOU | Founder | 52 | 21/01/91 |
Zhi Gao Ya
DFI | Director of Finance/CFO | 45 | 27/04/20 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Rong Yu
FOU | Founder | 52 | 21/01/91 |
Mei Ling Guo
BRD | Director/Board Member | 54 | 15/10/15 |
Chao Zhu
BRD | Director/Board Member | 44 | 19/01/22 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.39% | 2 M€ | -16.59% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 4.81 | +5.02% | 73,999,000 |
| 25/04/24 | 4.58 | +2.23% | 68,177,920 |
| 24/04/24 | 4.48 | -1.10% | 35,712,550 |
| 23/04/24 | 4.53 | +0.89% | 36,932,410 |
| 22/04/24 | 4.49 | -1.75% | 53,252,780 |
End-of-day quote Shenzhen S.E., April 25, 2024
More quotes
Meinian Onehealth Healthcare Holdings Co, Ltd. specialises in the provision of healthcare services to businesses and individuals. Net sales break down by activity is as follows:
- professional medical examination services (96.7%): routine medical examination services, medical consultations, medical monitoring, etc.;
- other (3.3%).
At the end of 2021, the Group operates 613 medical examination centers in China.
All sales are made in China.
Calendar
29/04/2024
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
4.81
CNY
Average target price
8.197
CNY
Spread / Average Target
+70.41%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -19.97% | 2.58B | |
| -14.92% | 84.68B | |
| +13.30% | 81.12B | |
| +10.92% | 29.4B | |
| -12.71% | 16.73B | |
| -3.06% | 16.36B | |
| -2.63% | 14.92B | |
| -31.75% | 11.77B | |
| -1.42% | 11.72B | |
| +27.44% | 11.71B |
- Stock Market
- Equities
- 002044 Stock
